South Korea Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook

Name: South Korea Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biologics contract development and manufacturing organization (cdmo) market in South Korea is expected to reach a projected revenue of US$ 488.3 million by 2033. A compound annual growth rate of 7.7% is expected of South Korea biologics contract development and manufacturing organization (cdmo) market from 2026 to 2033.

South Korea biologics contract development and manufacturing organization (cdmo) product outlook (Revenue, USD million, 2021-2033)
- Monoclonal Antibodies (mAbs)
- Recombinant Proteins & Enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic Acid Therapeutics
- Other Product
South Korea biologics contract development and manufacturing organization (cdmo) service outlook (Revenue, USD million, 2021-2033)
- Packaging and Labelling
- Regulatory Affairs
- Logistics & Storage
- Other Service
- Contract Development
  - Cell Line Development
  - Analytical Testing & Method Validation
  - Scale-Up & Tech Transfer
  - Process Development
    - Upstream
    - Downstream
- Contract Manufacturing
  - API Manufacturing
  - Finished Drug Products Manufacturing
South Korea biologics contract development and manufacturing organization (cdmo) source outlook (Revenue, USD million, 2021-2033)
- Mammalian
- Microbial
South Korea biologics contract development and manufacturing organization (cdmo) workflow outlook (Revenue, USD million, 2021-2033)
- Commerical
- Clinical
South Korea biologics contract development and manufacturing organization (cdmo) therapeutic area outlook (Revenue, USD million, 2021-2033)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Neurological Diseases
- Other Therapeutic Area
South Korea biologics contract development and manufacturing organization (cdmo) end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Academic and Research Institutions
- Other End Use

South Korea Biologics Contract Development And Manufacturing Organization (Cdmo) Market Size & Outlook

Sign up - it's easy, and free!